India Aiming For The Sky With Its Vaccination Target, Says SBI Research
BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
SBI Research Report
When compared to top 20 countries with maximum number of confirmed cases and with median age between 20-35 years, India fares significantly better in terms of fatality rate, recovery rate, deaths per million, tests per million.
In particular, only one country, Nepal has higher recovery rate than India. In case of fatality rate, only four countries Turkey, Nepal, Jordan and Israel have better performance compared to India.
Meanwhile, a new strain has already reached a couple of countries.
Though the countries have started vaccination programme, only a small percentage of population have been given the first dose of vaccine so far and by the time they receive the second dose they might spread the infection to many people.
Click on the attachment to read the full report:
This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BloombergQuint.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.